Memantine suppresses the glutamatergic neurotransmission of mammalian inner hair cells

ORL

Volumn 60, Issue 1, 1998, Pages 18-21

  Oestreicher, Elmar ^a,b   Arnold, Wolfgang ^a   Ehrenberger, Klaus ^c   Felix, Dominik ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cochlea; Glutamate; Inner ear therapy; Inner hair cells; Iontophoresis; Memantine; N methyl D asparate; Neurotransmission; Tinnitus

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; COCHLEA; FEMALE; HAIR CELL; IONTOPHORESIS; ISCHEMIA; NERVE CONDUCTION; NOISE INJURY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSORY NERVE; SYNAPSE; TINNITUS;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; GUINEA PIGS; HAIR CELLS, INNER; MEMANTINE; N-METHYLASPARTATE; NEURONS, AFFERENT; NEUROTRANSMITTER AGENTS; SYNAPTIC TRANSMISSION;

EID: 0031896294     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027556     Document Type: Article

References (21)

1. Eybalin M: Neurotransmitters and neuromodulators of the mammalian cochlea. Physiol Rev 1993;73:309-373.
2. Ehrenberger K, Felix D: Glutamate receptors in the afferent cochlear neurotransmission in guinea pigs. Hear Res 1991;52:73-80.
3. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;1: 623-634.
4. Pujol R, Puel J-L, D'Aldain CG, Eybalin M: Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol (Stockh) 1993; 113:330-334.
5. Evans EF, Borerwe TA: Ototoxic effects of salicylates on the responses of single cochlear nerve fibres and on cochlear potentials. Br J Audiol 1982;16:101-108.
6. Moller AR: Pathophysiology of tinnitus. Ann Otol Rhinol Laryngol 1984;93:39-44.
7. Ehrenberger K, Felix D: Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: A survey. Acta Otolaryngol (Stockh) 1995;115:236-240.
8. Ehrenberger K, Denk DM, Felix D: Rezeptor-pharmakologische Modelle für eine kausale Tinnitustherapie. Otorhinolaryngol Nova 1995;5:148-152.
9. Bormann J: Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 1989;166:591-592.
10. 3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 1989; 166:589-590.
11. Fischer P-A, Jacobi P, Schneider E, Schönberger B: Die Wirkung intravenöser Gaben von Memantine bei Parkinson-Kranken. Drug Res 1977;27:1487-1489.
12. Ditzler K: Efficacy and tolerability of memantine in patients with dementia syndrome. Drug Res 1991;41:773-780.
13. Oestreicher E, Arnold W, Ehrenberger K, Felix D: Memantine inhibits glutamatergic neurotransmission of inner hair cells of guinea pigs (abstract 025). 34th Workshop on Inner Ear Biol, Sept 1997, Rosa Marina, Italy.
14. Chen H-SV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA: Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992;12: 4427-4436.
15. Parsons CG, Gruner R, Rozental J, Millar J, Lodge D: Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 1993;32:1337-1350.
16. Parsons CG, Panchenko VA, Pinchenko VO, Tsyndrenko AY, Kristhal OA: Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine. Eur J Neurosci 1996;8: 446-454.
17. Erdö SL, Schäfer M: Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate. Eur J Pharmacol 1991; 198:215-217.
18. Seif el Nasr M, Peruche B, Rossberg C, Mennel HD, Krieglstein J: Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur J Pharmacol 1990;185:19-24.
19. Weller M, Finiels-Marlier F, Paul SM: NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: Neuroprotective properties of amantadine and memantine. Brain Res 1993;613: 143-148.
20. Weller M, Komhuber J: Pathophysiology and therapy of malignant neuroleptic syndrome. Nervenarzt 1991;63:645-655.
21. Kornhuber J, Quack G: Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man. Neurosci Lett 1995;195:137-139.